Türkcü Fatih Mehmet, Yüksel Harun, Şahin Alparslan, Murat Mehmet, Bozkurt Yaşar, Çaça Ihsan
Department of Ophthalmology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
Int Ophthalmol. 2013 Apr;33(2):177-80. doi: 10.1007/s10792-012-9646-x. Epub 2012 Oct 14.
Phosphodiesterase-5 (PDE5) inhibitors are commonly used in the treatment of erectile dysfunction. There are a small number of case reports that associate this agent with central serous chorioretinopathy (CSCR). Our report presents the treatment approach to a 42-year-old patient who described blurred vision and metamorphopsia and was diagnosed with CSCR following the use of tadalafil, a PDE5 inhibitor.
磷酸二酯酶-5（PDE5）抑制剂常用于治疗勃起功能障碍。有少数病例报告将该药物与中心性浆液性脉络膜视网膜病变（CSCR）相关联。我们的报告介绍了一名42岁患者的治疗方法，该患者出现视力模糊和视物变形，在使用PDE5抑制剂他达拉非后被诊断为CSCR。
